Expensive processed meals and fatty, chemical-laden treats are highly profitable, as a trip to any supermarket, where they ...

Explore Xeris Biopharma's revenue growth, promising pipeline, & thriving products. Learn about their strong outlook & ...

An orange a day, regular moderate-to-vigorous exercise, and GLP-1 drugs for diabetes treatment have all been linked to a ...

By screening people for eating disorders and disordered eating before these medications are prescribed, we can prevent ...

Use of cystatin C for chronic kidney disease evaluation and sodium–glucose cotransporter-2 inhibitors as first-line therapy ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

GLP-1 receptor agonists (GLP-1RAs) were initially approved for diabetes treatment (e.g., Ozempic®) but have revolutionized weight management ...

While the exact number of people with chronic kidney disease in South Africa is unclear, estimates suggest it could be as ...

Novo Nordisk Philippines and PCEDM have teamed up to tackle Type 2 diabetes, aiming to improve management and care through a ...

GLP-1 agonists can also come with other unpleasant side effects, like nausea and constipation. Meanwhile, a nimal testing of BRP showed no sign of these side-effects, or muscle loss, perhaps because ...

Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...